Skip Navigation
Research News

March 12, 2014
Genomic Medicine Institute study details whole-genome sequencing research

A new study by researchers from Geisinger Health System's Genomic Medicine Institute (GMI) found that it takes an average of four months to conduct the comprehensive case review prior to whole genome sequencing (WGS) clinical research -- time well spent in unraveling cognitive mysteries for some pediatric patients. Read more

February 26, 2014
Geisinger Genomics Medicine researchers assess ovarian cancer gene study

Geisinger genetic researchers provide perspective on a study published this week finding that healthy women with specific inherited gene mutations (BRCA1 and BRCA2) who protectively had their ovaries and fallopian tubes removed reduced their risk of ovarian, fallopian tube, or peritoneal cancer by 80 percent, and their overall risk of death by 77 percent. Read more

October 04, 2013
Geisinger receives award from Patient-Centered Outcomes Research Institute to study communication of genomic lab results

Geisinger Health System's Genomic Medicine Institute has been approved to receive a $1.4 million research award from the Patient-Centered Outcomes Research Institute to study how best to share genomic lab results with patients. The study is part of a portfolio of projects that will advance the field of patient-centered comparative effectiveness research and provide patients with information that will help them make better-informed decisions about their care. Read more

September 26, 2013
Geisinger genomics researchers take leading role in Clinical Genome Project

Four Geisinger Health System researchers have taken center stage in the national arena of genomics thanks to new funding from the National Human Genome Research Institute (NHGRI), an arm of the U.S. National Institutes of Health (NIH). It recently awarded three grants totaling $25 million to initiate the Clinical Genome (ClinGen) Project. Read more

September 16, 2013
Geisinger study provides score system to predict likelihood of diabetes remission after weight-loss surgery

Geisinger researchers have developed a simple scoring system (DiaRem), based on four readily available preoperative patient characteristics, that can predict which candidates for gastric bypass surgery are likely to achieve Type 2 diabetes remission within five years. Read more

September 16, 2013
Exposure to pig farms and manure fertilizers associated with MRSA infections

Researchers from Geisinger's Henry Hood Center for Health Research and Johns Hopkins Bloomberg School of Public Health have for the first time found an association between living in proximity to high-density livestock production and community-acquired infections with methicillin-resistant Staphylococcus aureus, commonly known as MRSA. Read more

May 28, 2013
David Evans receives presidential award from Bucknell

David Evans, PhD, professor of psychology at Bucknell University and senior investigator in the Autism and Developmental Medicine Institute, recently received the university's Presidential Award for Teaching Excellence. Read more

May 17, 2013
New genetic evidence suggests a continuum among neurodevelopmental and psychiatric disorders

A paper published this month in the prestigious medical journal The Lancet Neurology suggests that a broad spectrum of developmental and psychiatric disorders, ranging from autism and intellectual disability to schizophrenia, should be conceptualized as different manifestations of a common underlying denominator, "developmental brain dysfunction," rather than completely independent conditions with distinct causes. Read more

February 18, 2013
Degenstein Foundation invests $1 million in Geisinger research project

The Degenstein Foundation has awarded Geisinger Health System a $1 million grant to assist in underwriting its study into the potential health impacts of Marcellus shale gas drilling. Read more

August 27, 2012
Guthrie Health and Geisinger collaborate on Marcellus shale research

Guthrie Health, a healthcare system serving northern Pennsylvania and southern New York, has joined with Geisinger Health System to study the health impacts of Marcellus Shale gas drilling, the first large-scale, scientifically rigorous assessment of the health effects of natural gas production. Read more

August 22, 2012
Geisinger receives $1 million research grant from Pennsylvania State Department of Health

Geisinger Clinic, together with Cernostics, a life science firm developing advanced cancer diagnostic tests, the University of Pittsburgh, and the University of Pennsylvania, has been awarded a research grant from the state Department of Health that will be used to develop a test that predicts the risk of developing esophageal cancer in patients with chronic gastro-esophageal reflux disease (GERD) and Barrett's Esophagus. Read more

January 26, 2012
Geisinger researchers find genetic abnormalities may cause cerebral palsy

For years it was thought that a difficult birth and other perinatal factors were the leading causes of cerebral palsy. Now, researchers at Geisinger Health System find that the majority of cerebral palsy causes may in fact be caused by genetic abnormalities. Read more